Home » Stocks » QTNT

Quotient Limited (QTNT)

Stock Price: $6.84 USD 0.38 (5.88%)
Updated November 25, 4:00 PM EST - Market closed
After-hours: $6.85 +0.01 (0.15%) Nov 25, 5:49 PM

Stock Price Chart

Key Info

Market Cap 551.60M
Revenue (ttm) 41.63M
Net Income (ttm) -92.62M
Shares Out 80.64M
EPS (ttm) -1.16
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day November 25
Last Price $6.84
Previous Close $6.46
Change ($) 0.38
Change (%) 5.88%
Day's Open 6.61
Day's Range 6.40 - 6.93
Day's Volume 1,016,632
52-Week Range 2.40 - 10.38

More Stats

Market Cap 551.60M
Enterprise Value 562.15M
Earnings Date (est) Feb 8, 2021
Ex-Dividend Date n/a
Shares Outstanding 80.64M
Float 73.11M
EPS (basic) -1.17
EPS (diluted) -1.16
FCF / Share -0.87
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 5.06M
Short Ratio 9.63
Short % of Float 6.92%
Beta 2.43
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 13.25
PB Ratio 19.36
Revenue 41.63M
Operating Income -76.65M
Net Income -92.62M
Free Cash Flow -72.67M
Net Cash -10.55M
Net Cash / Share -0.13
Gross Margin 35.68%
Operating Margin -184.11%
Profit Margin -222.50%
FCF Margin -174.56%
ROA -20.78%
ROE n/a
ROIC -18.80%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

(85.23% upside)
Current: $6.84
Target: 12.67
*Average 12-month price target from 3 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth12.09%17.8%11.27%20%0.62%-6.82%37.46%17.61%21.78%-
Gross Profit14.8611.9014.2611.388.868.6511.357.205.474.41
Operating Income-80.69-78.96-69.99-74.06-49.09-29.71-8.89-4.49-3.96-4.10
Net Income-103-105-82.34-85.07-33.88-59.06-10.17-4.71-4.47-4.62
Shares Outstanding71.6154.8740.8428.1519.5614.770.
Earnings Per Share-1.44-1.92-2.02-3.02-1.73-4.00-54.41-62.97-78.04-81.16
Operating Cash Flow-80.65-75.66-68.42-56.20-46.97-26.59-4.38-3.62-3.07-3.56
Capital Expenditures-4.60-4.79-1.86-20.16-28.91-23.85-7.23-0.89-0.35-0.09
Free Cash Flow-85.24-80.45-70.28-76.36-75.88-50.45-11.61-4.51-3.42-3.65
Cash & Equivalents13010230.8725.8544.1037.537.194.224.35-
Total Debt17812387.0082.2530.7914.8715.443.513.10-
Net Cash / Debt-47.88-20.86-56.13-56.4013.3222.66-8.250.711.26-
Book Value-5.531.71-14.63-24.0946.72-1.62-31.54-23.06-18.69-
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Quotient Limited
Country Switzerland
Employees 420
CEO Franz Walt

Stock Information

Ticker Symbol QTNT
Stock Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Unique Identifier NASDAQ: QTNT
IPO Date April 25, 2014


Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. The company is developing MosaiQ, a proprietary technology platform, which provides tests for immunohematology and serological disease screening. Its conventional reagent products for blood grouping include antisera products that are used to identify blood group antigens; reagent red blood cells, which enable the identification of blood group antibodies; whole blood control products for use as daily quality assurance tests; and ancillary products that are used to support blood grouping. The company is also developing microarray-based SARS-CoV-2 antibody test for use on the MosaiQ platform for COVID-19. It sells its products to hospitals, donor collection agencies, independent testing laboratories, original equipment manufacturers, and blood banking operation and other diagnostics companies. Quotient Limited was founded in 2007 and is headquartered in Eysins, Switzerland.